MedPath

KINDAI UNIVERSITY

KINDAI UNIVERSITY logo
🇯🇵Japan
Ownership
Private
Established
1949-01-01
Employees
-
Market Cap
-
Website
https://www.kindai.ac.jp

PRasugrEl Monotherapy Following prImary percUtaneous Coronary Intervention for ST-elevation Myocardial Infarction

Phase 4
Recruiting
Conditions
ST-segment Elevation Myocardial Infarction (STEMI)
Interventions
First Posted Date
2023-02-02
Last Posted Date
2023-03-01
Lead Sponsor
Kindai University
Target Recruit Count
2258
Registration Number
NCT05709626
Locations
🇯🇵

Kindai University Faculty of Medicine, Osakasayama, Osaka, Japan

Decreased Tongue Strength is Related to Skeletal Muscle Mass in COPD Subjects

Completed
Conditions
Chronic Obstructive Pulmonary Disease
Interventions
Diagnostic Test: balloon-based tongue pressure measurement device
First Posted Date
2021-02-18
Last Posted Date
2021-02-18
Lead Sponsor
Kindai University
Target Recruit Count
51
Registration Number
NCT04761380
Locations
🇯🇵

Kindai University Faculty of Medicine, Ōsaka-sayama, Osaka, Japan

Study to Evaluate ctDNA of mCSPC Patients Receiving Apalutamide in Japan

Phase 4
Recruiting
Conditions
Metastatic Castration-sensitive Prostate Cancer
Interventions
First Posted Date
2020-10-23
Last Posted Date
2020-12-08
Lead Sponsor
Kindai University
Target Recruit Count
100
Registration Number
NCT04601441
Locations
🇯🇵

Kindai University Hospital, Ōsaka-sayama, Osaka, Japan

Pembrolizumab as Neoadjuvant Treatment in HCC

Phase 2
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2017-11-09
Last Posted Date
2017-11-09
Lead Sponsor
Kindai University
Target Recruit Count
50
Registration Number
NCT03337841

Prediction of Incidence of Liver Cancer by Use of Real-time Tissue Elastography

Conditions
Chronic Hepatitis B
Chronic Hepatitis C
First Posted Date
2011-05-26
Last Posted Date
2011-05-26
Lead Sponsor
Kindai University
Target Recruit Count
1000
Registration Number
NCT01360892
Locations
🇯🇵

Kinki University Faculty of Medicine, Osaka-sayama, Osaka, Japan

Assessment of Liver FIBROsis by Real-time Tissue ELASTography in Chronic Liver Disease

Conditions
Chronic Hepatitis C
Chronic Hepatitis B
First Posted Date
2011-05-26
Last Posted Date
2011-05-26
Lead Sponsor
Kindai University
Target Recruit Count
500
Registration Number
NCT01360879
Locations
🇯🇵

Kinki University Faculty of Medicine, Osaka-sayama, Osaka, Japan

Transcatheter Arterial Chemoembolization Therapy In Combination With Sorafenib

Phase 2
Conditions
Hepatocellular Carcinoma
Unresectable Hepatocellular Carcinoma
Carcinoma, Hepatocellular
Liver Neoplasm
Interventions
Drug: TACE with sorafenib
Procedure: TACE alone
First Posted Date
2010-10-08
Last Posted Date
2017-10-31
Lead Sponsor
Kindai University
Target Recruit Count
228
Registration Number
NCT01217034
Locations
🇯🇵

Kinki University Hospital, Osaka-Sayama, Osaka, Japan

Study of Sorafenib In Combination With Low-dose 5-fluorouracil/Cisplatin (FP) Intraarterial Infusion Chemotherapy

Phase 1
Completed
Conditions
Hepatocellular Carcinoma
Interventions
First Posted Date
2009-07-07
Last Posted Date
2010-11-25
Lead Sponsor
Kindai University
Target Recruit Count
37
Registration Number
NCT00933816
Locations
🇯🇵

Kurume University Medical Center, Kurume, Fukuoka, Japan

🇯🇵

Ogaki Municipal Hospital, Oogaki, Gifu, Japan

🇯🇵

Kinki University School of Medicine, Osaka-Sayama, Osaka, Japan

Sonazoid Enhanced Liver Cancer Trial for Early Detection

Not Applicable
Conditions
Hepatitis C
Liver Cirrhosis
Hepatocellular Carcinoma
Hepatitis B
Interventions
Device: CE-US (Sonazoid™)
Device: B-mode US
First Posted Date
2009-01-15
Last Posted Date
2010-12-30
Lead Sponsor
Kindai University
Target Recruit Count
760
Registration Number
NCT00822991
Locations
🇯🇵

Kinki University School of Medicine, Department of Gastroenterology and Hepatology, Osaka-Sayama, Osaka, Japan

© Copyright 2025. All Rights Reserved by MedPath